Alex Nigg

Alex Nigg is an active Researcher in the Department of Pathology at Erasmus MC, with a robust publication record spanning molecular biology, cancer research, and immunology. Their work demonstrates significant contributions to understanding nucleosome dynamics, tumor progression mechanisms, and lipid metabolism in disease contexts.

Research interests focus on the intersection of molecular biology and pathology, particularly examining how chromatin remodeling influences cancer development and immune responses. Nigg's work bridges basic science with clinical applications, especially in oral cancer, melanoma, and pancreatic cancer models. Their research employs advanced techniques including live-cell imaging, bioluminescence tracking, and lipidomic profiling to uncover novel disease mechanisms.

Recent publications reveal a strong trend toward interdisciplinary approaches, combining molecular biology with computational methods and imaging technologies. The research spans cancer biology, immunology, and metabolic pathways, with particular emphasis on how epigenetic regulation and microRNA networks influence tumor progression and therapeutic responses. Nigg's work shows increasing focus on translational applications, particularly in developing diagnostic tools for cancer detection and monitoring immune responses.

Nigg has established productive collaborations across multiple institutions, as evidenced by co-authorship on diverse research projects. Their work has garnered attention in academic circles with citations across multiple publications and readership on academic platforms. The research output demonstrates consistent productivity with multiple high-impact publications appearing in leading journals across pathology, oncology, and molecular biology fields.